Tom Gallen
Managing Editor – Europe
Latest From Tom Gallen
Nestlé Spies APAC Expansion Potential With Deal for New Zealand's Better Health
Nestlé Health Science continues to expand its dietary supplements offering in 2022 penning a deal for New Zealand's The Better Health Company and its GO Healthy brand. The company says the deal will strengthen its presence not just in New Zealand but across the wider APAC region in markets such as Australia and China.
People On The Move: Appointments At CRN UK, EMA, Boots
A round-up of the latest European executive appointments: CRN UK hires scientific advisor; EMA management board names vice chair; Boots UK appoints chief digital officer.
France's Havea Set For New Private-Equity Owners
French natural consumer health specialist Havea looks set to be snapped up by private-equity firm BC Partners, which has set out a plan to step up the company's M&A and digitization activities.
EU Novel Food Approvals: Yes To Vit D Mushroom Powder, No To New Zinc Source
Two novel food applications were recently reviewed by the European Food Safety Authority, with one from Monterey Mushrooms for vitamin D2 mushroom powder approved, and another from Hamari Chemicals for a new source of zinc rejected.
EU Restricts Red Yeast Rice Supplements Over Safety Concerns
Restrictions on daily doses and mandatory label warnings now apply to dietary supplements containing monacolins from red yeast rice sold in the EU following long-running safety concerns about the substance.
People On The Move: Appointments At ProBiotix, EMA, Neuraxpharm
A round-up of the latest European industry appointments: ProBiotix Health names Steen Andersen as its first permanent CEO; EMA appoints Steffen Thirstrup as chief medical officer; Neuraxpharm hires former Almirall exec Alfredo Barón to lead its Spanish business.